⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL997657 | 0.81 | ALDH1A1 (0.40) | — | |
| Ethylene Glycol SCHEMBL11202815 | 0.79 | ALDH1A1 (0.36) | — | |
| SCHEMBL7850062 | 0.79 | — | — | |
| SCHEMBL11221322 | 0.78 | ALDH1A1 (0.39) | — | |
| SCHEMBL3999459 | 0.77 | — | — | |
| Ethylene Glycol SCHEMBL27698775 | 0.77 | TSHR (0.44) | — | |
| Ethylene SCHEMBL4036431 | 0.75 | ALDH1A1 (0.37) | — | |
| Ethylene SCHEMBL8717309 | 0.75 | ALDH1A1 (0.37) | — | |
| Ethylene SCHEMBL8080273 | 0.75 | ALDH1A1 (0.37) | — | |
| SCHEMBL1052625 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 525 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116715644-A | Spiromesifen derivative, preparation method and application thereof | 河南蓝创作物科学有限公司 | 2023-09-08 | — | — | CN | claimed |
| EP-2373633-B1 | METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES | BOREALIS AGROLINZ MELAMINE (AT) | 2014-04-16 | — | — | EP | claimed |
| US-20110295001-A1 | Method for Producing Triazine Carbamates Using Chloroformates | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2011-12-01 | — | — | US | claimed |
| EP-1879867-A2 | INTERMEDIATES FOR PREPARING SOLIFENACIN | Teva Pharmaceutical Industries Ltd (IL) | 2008-01-23 | — | — | EP | claimed |
| WO-2007076116-A2 | INTERMEDIATES FOR PREPARING SOLIFENACIN | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-07-05 | — | — | WO | claimed |
| EP-4714446-A2 | PHARMACEUTICAL COMPOUNDS | Nxera Pharma UK Limited (GB) | 2026-03-25 | — | — | EP | disclosed |
| US-12552767-B2 | 3-heteroaryl pyrrolidine and piperidine orexin receptor agonists | MERCK SHARP & DOHME LLC (US) | 2026-02-17 | — | — | US | disclosed |
| US-12528827-B2 | Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-01-20 | — | — | US | disclosed |
| US-20250388531-A1 | SUBSTITUTED TETRACYCLINE COMPOUNDS | PARATEK PHARM INNC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12441731-B2 | Pyrazolopyrimidine compounds and uses thereof | INCYTE CORPORATION (US) | 2025-10-14 | — | — | US | disclosed |
| WO-2025202481-A1 | PRODRUGS OF LYSERGAMIDES | MIHKAL GMBH (CH) | 2025-10-02 | — | — | WO | disclosed |
| EP-4263646-B1 | STABILIZED EPOXY-ISOCYANATE MIXTURES AND OXAZOLIDINONE CONTAINING POLYMERS OBTAINED THEREFROM | BASF SE (DE) | 2025-02-12 | — | — | EP | disclosed |
| WO-2003045924-A1 | SUBSTITUTED ARYL 1,4-PYRAZINE DERIVATIVES | PHARMACIA & UPJOHN COMPANY (US) | 2003-06-05 | — | — | WO | disclosed |
| WO-2002079192-A1 | NOVEL TYROSINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-10-10 | — | — | WO | disclosed |
| US-20020111313-A1 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2002-08-15 | — | — | US | disclosed |
| WO-2002060926-A2 | HEPATITIS C TRIPEPTIDE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-08-08 | — | — | WO | disclosed |
| US-4376731-A | 2-NITRILES THEREOF | BOEHRINGER MANNHEIM GMBH (DE) | 1983-03-15 | — | — | US | disclosed |
| US-4066440-A | SYMMETRICAL ALKYNYL UREAS | PPG INDUSTRIES, INC. (US) | 1978-01-03 | — | — | US | disclosed |
| US-4066440-A | SYMMETRICAL ALKYNYL UREAS | PPG INDUSTRIES, INC. (US) | 1978-01-03 | — | — | US | disclosed |
| US-4022609-A | MITICIDES | PPG INDUSTRIES, INC. (US) | 1977-05-10 | — | — | US | disclosed |